secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-08-19T23:59:59+00:00
Accession:  0000950170-24-098505
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences warns of delisting risk; stockholders' equity only $1.14M vs $2.5M minimum
--------------------------------------------------------------------------------

- Received Nasdaq letter on Aug 14, 2024, citing insufficient stockholders' equity of $1,140,421 vs required $2.5M.
- Also failed alternative listing standards (market value of listed securities ≥$35M or net income from continuing ops $500K).
- Company has 45 days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- No immediate effect on trading; common stock and warrants continue trading under REVB and REVBW.
- Company intends to take reasonable measures but no assurance of extension or regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024098505/0000950170-24-098505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024098505/revb-20240814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-098505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer